Patent · US Active

Imidazopyrazines

US9468642B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Ulrich Klar · Berlin, DE
Marcus Koppitz · Berlin, DE
Dirk Kosemund · Berlin, DE
Rolf Bohlmann · Berlin, DE
Benjamin Bader · Berlin, DE
Philip Lienau · Berlin, DE
Gerhard Siemeister · Berlin, DE
Stefan Prechtl · Berlin, DE
Duy Nguyen · Berlin, DE
William Scott · Guilford, US

Key dates

Filing date	Mar 16, 2011
Grant date	Oct 18, 2016
Priority date	—
Expiry date	Mar 28, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to imidazopyrazine compounds of general Formula (I): in which X, R1, R2, R3a, R3b, R4a, R4b, R4C, and R4D are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.